ALK and adenocarcinoma: Experience with IO alone or in combination with chemotherapy (CT) is limited in transformed-ALK patients, and to date, there are no studies evaluating the role of CT and IO in patients with SCLC transformed from adenocarcinoma with ALK translocation.